[url="]Schall, Brown and Schwartz LLP[/url] (“SBS”), a national shareholder rights litigation fi

LOS ANGELES--(BUSINESS WIRE)---- $CC--CC Investors Have Opportunity to Lead The Chemours Company Sec

SAN DIEGO--(BUSINESS WIRE)---- $CC #CC--Robbins LLP is investigating whether Chemours materially ove

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages The Chemours Company (CC) Shar

Ripple closed three major institutional deals in a single day, but signing contracts and actually ne

Chemours (NYSE:CC) held its second-quarter earnings conference call on Wednesday. Below is the compl

Chemours (NYSE: CC - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) a

UBS analyst Joshua Spector maintains Chemours (NYSE:CC) with a Neutral and lowers the price targe

Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price t

Chemours PFAS settlement lifts shares as the $455 million deal clarifies liabilities, payment timing

The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Ne

JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the pr

BMO Capital analyst John McNulty maintains Chemours (NYSE:CC) with a Outperform and lowers the pr

Analysts update ratings on top stocks. View all changes, including upgrades and downgrades, on anal

UBS analyst Joshua Spector downgrades Chemours (NYSE:CC) from Buy to Neutral and lowers the price

 The products further expand the industry-leading Opteon™ portfolio and provide customers with addit

RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and lowers th

Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the

Chemours (NYSE:CC) widens FY2026 sales outlook from $5.982 billion-$6.098 billion to $5.866 billion-

Chemours (NYSE:CC) reported quarterly earnings of $0.42 per share which met the analyst consensus es

Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price t

JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and raises the pr

Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:CC) with a Equal-Weight and raise

Analysts changed outlook on top names, RBC raised CC price target, DA Davidson lowered MSA target, O

Wall Street has rarely been louder with bubble warnings on the AI trade after the parabolic moves we

RBC Capital analyst Arun Viswanathan maintains Chemours (NYSE:CC) with a Outperform and raises th

Memory is yesterday's trade. Liquid cooling is the next AI backlog story — Carrier orders up 500

Full Year 2026 Outlook The Company continues to expect 2026 Net Sales to grow in the range of 3% to

Second Quarter 2026 Outlook In the second quarter, the Company anticipates consolidated Net Sales to

Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and raises the

Dow Jones up 150 pts, Citi Trends $CTRN up 20.8% on strong earnings, other big gainers include Getty

DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B.

Chemours Company reports Q4 net sales of $1.359 billion, in line with consensus. Adjusted EBITDA imp

Chemours shares fall as internal review reveals delayed payments and lack of transparency in managem

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnin

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued com

Companies Reporting Before The Bell • SES AI (NYSE:SES) is projected to report quarterly earnings a

U.S. stocks traded higher, with the Dow Jones gaining over 400 points on Friday. Here are some big s